Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development is a research paper published in Cells (2022). On theSindex it has a DataRank of 0. It has been cited 38 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: RO1DK117504
National Institutes of Health
Grant: RO1AG062355
National Institutes of Health
Grant: RF1AG062661
NIA NIH HHS
Grant: R01 AG062355
NIDDK NIH HHS
Grant: R01 DK117504
National Institutes of Health
Grant: 5R01AG062355-02
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease
National Institutes of Health
Grant: 1RF1AG062661-01
VGF peptide TLQP-21, a novel microglial C3aR1 modulator in Alzheimer's disease
National Institutes of Health
Grant: 5R01DK117504-03
Neural mechanisms for VGF regulation of energy balance
Cure Alzheimer’s Fund
FWCI
5.71
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals